Donor-Derived Myeloid Neoplasm Post Allogeneic Hematopoietic Cell Transplantation

Blood - United States
doi 10.1182/blood-2016-10-747550
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Impacts of Post-Transplantation Cyclophosphamide Treatment After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2019English

Frequency of Hospital Readmissions Post Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Haematologica
Hematology
2016English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia

Cancer Control
MedicineOncologyHematology
2011English

Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Successful Treatment of Griscelli Syndrome With Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2002English

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy